December 10, 2025- Medtronic plc announced that Ryan Weispfenning, vice president and head of investor relations, has elected to join its Diabetes business to establish and lead the investor relations function for MiniMed, the planned New Diabetes Company. Ryan brings over 25 years of experience with Medtronic to his new role. He has been a member of the Medtronic investor relations team for the past 17 years, including leading the function for more than a decade.
The company also announced that Ingrid Goldberg will join Medtronic as vice president and head of investor relations. Goldberg brings more than 20 years of industry experience, spanning the financial, medical device, and life science sectors. Most recently, Goldberg served as vice president of finance and investor relations at Novocure, where she led the investor relations, communications, and business development functions.